As of September 18, 2025, President Donald Trump (R) had signed 204 executive orders, 51 memoranda, and 86 proclamations in his second presidential term, which began on January 20, 2025. Each type of ...

Apple's iPhone 17 "Awe dropping" event is scheduled for Tuesday, September 9, at 10:00 a.m. Pacific Time. If Apple follows the traditional pattern, iPhone 17 pre-orders will begin later this week on ...

Sep 6, 2025; Madison, Illinois, USA; NASCAR Xfinity Series driver Connor Zilisch (88) celebrates after winning the Nu Way 200 Sauced by Blues Hog at World Wide Technology Raceway. Mandatory Credit: ...

Happy Onam 2025: Onam is a vibrant 10-day harvest festival celebrated by the Malayali community in Kerala and around the world. In 2025, the festivities began on August 26 and will culminate with ...

WEST PALM BEACH, Fla. — The WPTV First Alert Weather team is tracking Tropical Wave Invest 91-L in the central Atlantic Ocean. The National Hurricane Center said Friday that the system now has a 30% ...

Women are turning away from motherhood in their droves because the pressures of second wave feminism have made the lives of many new mothers intolerable, Peter Hitchens has argued. Speaking on the ...

Helldivers 2 has all sorts of various enemy types to kill within each of the three factions. The Terminid are bug-like creatures that have all sorts of breeds despite mutating from the same spores, ...

Abstract: Reconfigurable intelligent surface (RIS) with 1-bit phase resolution suffers from high side lobe levels (SLLs) in the near field and pronounced quantization lobe levels (QLLs) in the far ...

Vikran Engineering Share Price LIVE Updates: Vikran Engineering IPO listing date is today, and the equity shares are listed on BSE and NSE.(Photo: Company Website) Vikran Engineering Share Price ...

Apple is expected to unveil the iPhone 17 series, including the Pro Max, on September 9. Leaks suggest a redesigned rear camera with a raised rectangular module. The Pro Max may include an 8x ...

Amgen's bemarituzumab trial has taken a turn, with a final analysis showing weaker survival benefits than previously found in an earlier pre-specified interim analysis. In June, Amgen and China ...